P.J. McLaren

Discipline

Anthropologie biologique (6) Géographie (1) Economies et finances (1)

Type de document

Articles (25) Recensions (3)

Co-auteur

Date

Source

Mot-clé

association (14) Social groups (14) infection (11) Infection (11) variation génétique (10) Genes (10) Human beings (10) analyse (9) maladie (9) Patients (9) Analysis (9) Patients (9) maladie (9) gène (8) Population (8) risque (7) Variation (7) Control (7) Risk (7) Population (7) Selection (6) Number (6) roman (6) virus (5) effet (5) Testing (5) Treatment (5) Cases (5) Testing (5) Manufacturers' agents (5)

Documents écrit par P.J. McLaren (25) | parle de P.J. McLaren (0)

Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV.
A.G. Bick et al. (12 janv. 2022)
A high-resolution HLA reference panel capturing global population diversity enables multi-ancestry fine-mapping in HIV host response.
Y. Luo et al.
HIV-1 and human genetic variation.
P.J. McLaren et al.
Genetic variation near CXCL12 is associated with susceptibility to HIV-related non-Hodgkin lymphoma.
C.W. Thorball et al. (1 août 2021)
The influence of human genetic variation on Epstein-Barr virus sequence diversity.
S. Rüeger et al. (25 févr. 2021)
Dissemination of Mycobacterium tuberculosis is associated to a SIGLEC1 null variant that limits antigen exchange via trafficking extracellular vesicles.
S. Benet et al.
HLA Heterozygote Advantage against HIV-1 Is Driven by Quantitative and Qualitative Differences in HLA Allele-Specific Peptide Presentation.
J. Arora et al. (1 mars 2020)
Privacy-preserving genomic testing in the clinic: a model using HIV treatment.
P.J. McLaren et al.
Identification of potential HIV restriction factors by combining evolutionary genomic signatures with functional analyses.
P.J. McLaren et al. (2015)
Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection.
K. Fitzmaurice et al. (2015)
Defining the role of common variation in the genomic and biological architecture of adult human height.
A.R. Wood et al.
HIV-1 capture and transmission by dendritic cells: the role of viral glycolipids and the cellular receptor Siglec-1.
N. Izquierdo-Useros et al. (2014)
Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202.
D.H. Johnson et al. (2014)
Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group Study
T.J. Henrich et al. (2014)
Analysis of stop-gain and frameshift variants in human innate immunity genes.
A. Rausell et al. (2014)
Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.
P.D. Leger et al. (2014)
A Novel Acute Retroviral Syndrome Severity Score Predicts the Key Surrogate Markers for HIV-1 Disease Progression.
D.L. Braun et al. (2014)
Disentangling human tolerance and resistance against HIV.
R.R. Regoes et al. (2014)
GuavaH: a compendium of host genomic data in HIV biology and disease.
I. Bartha et al. (2014)
A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control.
I. Bartha et al. (2013)
Susceptibility and adaptation to human TRIM5α alleles at positive selected sites in HIV-1 capsid.
N. Rahm et al. (2013)
A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A.
J. Lane et al. (2013)
Association Study of Common Genetic Variants and HIV-1 Acquisition in 6,300 Infected Cases and 7,200 Controls.
P.J. McLaren et al. (2013)
HIV and innate immunity ? a genomics perspective
A. Rausell et al. (2013)
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
F. Pereyra et al. (2010)